UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1282) 1282
science & technology (1252) 1252
life sciences & biomedicine (1194) 1194
topotecan (859) 859
oncology (835) 835
biological and medical sciences (794) 794
medical sciences (781) 781
female (721) 721
pharmacology. drug treatments (685) 685
antineoplastic agents (639) 639
chemotherapy (555) 555
topotecan - administration & dosage (489) 489
topotecan - pharmacology (468) 468
male (427) 427
animals (402) 402
middle aged (381) 381
pharmacology & pharmacy (377) 377
aged (360) 360
adult (356) 356
antineoplastic agents - pharmacology (339) 339
camptothecin - analogs & derivatives (311) 311
antineoplastic combined chemotherapy protocols - therapeutic use (285) 285
antineoplastic agents - therapeutic use (281) 281
mice (270) 270
topotecan - therapeutic use (269) 269
tumors (251) 251
cell line, tumor (242) 242
cancer (241) 241
topotecan - adverse effects (230) 230
topotecan - pharmacokinetics (228) 228
topoisomerase i inhibitors (213) 213
ovarian neoplasms - drug therapy (208) 208
dose-response relationship, drug (206) 206
antineoplastic agents - administration & dosage (195) 195
drug administration schedule (190) 190
camptothecin - pharmacology (187) 187
treatment outcome (181) 181
neoplasms - drug therapy (172) 172
antineoplastic agents - pharmacokinetics (168) 168
antineoplastic agents - adverse effects (161) 161
drug resistance, neoplasm (159) 159
lung neoplasms - drug therapy (156) 156
tumor cells, cultured (149) 149
antineoplastic combined chemotherapy protocols - adverse effects (126) 126
infusions, intravenous (123) 123
enzyme inhibitors - pharmacology (122) 122
ovarian cancer (121) 121
camptothecin - therapeutic use (117) 117
camptothecin (106) 106
dna topoisomerases, type i - metabolism (105) 105
irinotecan (105) 105
aged, 80 and over (102) 102
apoptosis (102) 102
medicine & public health (101) 101
apoptosis - drug effects (96) 96
research (96) 96
drug synergism (95) 95
cisplatin - administration & dosage (94) 94
general aspects (94) 94
mice, nude (94) 94
child (92) 92
analysis (90) 90
antineoplastic combined chemotherapy protocols - administration & dosage (90) 90
biochemistry & molecular biology (89) 89
pharmacokinetics (89) 89
cell survival - drug effects (88) 88
paclitaxel - administration & dosage (88) 88
pharmacology/toxicology (87) 87
care and treatment (86) 86
drug therapy (86) 86
neoplasm recurrence, local - drug therapy (86) 86
ovarian neoplasms - pathology (85) 85
camptothecin - administration & dosage (83) 83
xenograft model antitumor assays (83) 83
adolescent (82) 82
atp binding cassette transporter, sub-family g, member 2 (82) 82
chemistry (82) 82
physical sciences (82) 82
antimitotic agents (79) 79
administration, oral (77) 77
drug resistance (77) 77
antineoplastic combined chemotherapy protocols - pharmacology (76) 76
dna damage (76) 76
carcinoma, small cell - drug therapy (75) 75
antineoplastic agents, phytogenic - pharmacology (74) 74
survival analysis (73) 73
paclitaxel (72) 72
time factors (72) 72
child, preschool (71) 71
topoisomerase i inhibitors - pharmacology (71) 71
topotecan - chemistry (71) 71
drug screening assays, antitumor (70) 70
neutropenia - chemically induced (68) 68
survival rate (68) 68
camptothecin - pharmacokinetics (67) 67
cell proliferation - drug effects (67) 67
deoxycytidine - analogs & derivatives (67) 67
etoposide - administration & dosage (67) 67
gynecology. andrology. obstetrics (67) 67
hematology (66) 66
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1531) 1531
Chinese (19) 19
French (5) 5
Italian (4) 4
Russian (4) 4
Japanese (2) 2
Dutch (1) 1
German (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer research (Chicago, Ill.), ISSN 0008-5472, 06/2013, Volume 73, Issue 12, pp. 3683 - 3691
Life Sciences & Biomedicine | Oncology | Science & Technology | Gynecology. Andrology. Obstetrics | Pharmacology. Drug treatments | Biological and medical sciences | Multiple tumors. Solid tumors. Tumors in childhood (general aspects) | Medical sciences | Antineoplastic agents | Tumors | Female genital diseases | Protein Kinases - metabolism | Protein Kinases - genetics | Humans | Ovarian Neoplasms - pathology | Cell Survival - genetics | Deoxycytidine - pharmacology | Immunoblotting | Sulfones - pharmacology | Cell Cycle Proteins - antagonists & inhibitors | Dose-Response Relationship, Drug | Ovarian Neoplasms - genetics | RNA Interference | BRCA1 Protein - metabolism | Protein-Serine-Threonine Kinases - antagonists & inhibitors | Cell Cycle Proteins - genetics | Female | Antineoplastic Agents - pharmacology | Ovarian Neoplasms - metabolism | Phosphorylation - drug effects | cdc25 Phosphatases - metabolism | Protein-Serine-Threonine Kinases - metabolism | Pyrazoles - pharmacology | Cell Survival - drug effects | Topotecan - pharmacology | Cell Cycle Proteins - metabolism | Protein-Serine-Threonine Kinases - genetics | Signal Transduction - genetics | cdc25 Phosphatases - genetics | Ataxia Telangiectasia Mutated Proteins | Cisplatin - pharmacology | Pyrimidines - pharmacology | Poly(ADP-ribose) Polymerase Inhibitors | BRCA1 Protein - genetics | Poly(ADP-ribose) Polymerases - metabolism | BRCA2 Protein - metabolism | Signal Transduction - drug effects | Cell Line, Tumor | Benzimidazoles - pharmacology | Checkpoint Kinase 1 | Pyrazines - pharmacology | BRCA2 Protein - genetics | Deoxycytidine - analogs & derivatives | Index Medicus | homologous recombination | ovarian cancer | Poly(ADP-ribose) polymerase | veliparib | gemcitabine | BRCA1 | cisplatin | BRCA2 | topotecan
Journal Article
Clinical cancer research, ISSN 1078-0432, 04/2014, Volume 20, Issue 8, pp. 2104 - 2114
Journal Article
Science (American Association for the Advancement of Science), ISSN 0036-8075, 05/2016, Volume 352, Issue 6289, pp. aad7993 - aad7993
Journal Article
Journal of pharmaceutical sciences, ISSN 0022-3549, 12/2007, Volume 96, Issue 12, pp. 3226 - 3235
BCRP | drug interactions | inhibitor | active transport | cell culture | ABC transporters | drug resistance | efflux pumps | azole antifungal | ABCG2 | Active transport | Cell culture | Efflux pumps | Drug interactions | Azole antifungal | Inhibitor | Drug resistance | Physical Sciences | Chemistry | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Chemistry, Medicinal | Chemistry, Multidisciplinary | Science & Technology | Pharmaceutical technology. Pharmaceutical industry | Biological and medical sciences | Medical sciences | General pharmacology | Pharmacology. Drug treatments | ATP Binding Cassette Transporter, Sub-Family G, Member 2 | Fluconazole - pharmacology | Humans | Chlorophyll - analogs & derivatives | Fluorescent Dyes - metabolism | Ketoconazole - metabolism | Neoplasm Proteins - antagonists & inhibitors | Neoplasm Proteins - metabolism | Itraconazole - pharmacology | Ketoconazole - pharmacology | Dose-Response Relationship, Drug | Drug Interactions | Flow Cytometry | Transfection | ATP-Binding Cassette Transporters - genetics | Antifungal Agents - metabolism | Voriconazole | ATP-Binding Cassette Transporters - metabolism | Inhibitory Concentration 50 | Antineoplastic Agents - pharmacology | Neoplasm Proteins - genetics | Antifungal Agents - pharmacology | Itraconazole - metabolism | Cell Line | Cell Survival - drug effects | Topotecan - pharmacology | Chlorophyll - metabolism | Pyrimidines - pharmacology | Triazoles - pharmacology | ATP-Binding Cassette Transporters - antagonists & inhibitors | Drug Resistance, Neoplasm - drug effects | Index Medicus
Journal Article
Cell research, ISSN 1001-0602, 2012, Volume 22, Issue 8, pp. 1227 - 1245
突变基因 | 致死作用 | 肿瘤细胞 | 靶向治疗 | RAS基因 | oncogene addiction | proteasome | synthetic lethal | topoisomerase | KRAS | Life Sciences & Biomedicine | Science & Technology | Cell Biology | RNA, Small Interfering - genetics | ras Proteins - genetics | Colonic Neoplasms - genetics | Proto-Oncogene Proteins p21(ras) | Humans | Transcriptional Activation | Gene Expression Regulation, Neoplastic | ras Proteins - metabolism | Deoxycytidine - pharmacology | Colonic Neoplasms - metabolism | Gene Knockdown Techniques | Topoisomerase I Inhibitors - pharmacology | RNA Interference | Cell Transformation, Neoplastic - genetics | Cell Cycle Proteins - genetics | Antineoplastic Agents - pharmacology | Nuclear Proteins - genetics | GATA2 Transcription Factor - genetics | Proto-Oncogene Proteins - metabolism | Bortezomib | Topotecan - pharmacology | DNA Topoisomerases, Type I - metabolism | Proteasome Inhibitors - pharmacology | Cell Survival | Cell Cycle Proteins - metabolism | Nuclear Proteins - metabolism | Proto-Oncogene Proteins - genetics | Cell Transformation, Neoplastic - metabolism | Proteasome Endopeptidase Complex - genetics | Colonic Neoplasms - pathology | Alleles | GATA2 Transcription Factor - metabolism | Cell Line, Tumor | Mutation | Proteasome Endopeptidase Complex - metabolism | Pyrazines - pharmacology | Deoxycytidine - analogs & derivatives | Apoptosis | Boronic Acids - pharmacology | RNA, Small Interfering - metabolism | Index Medicus | Original
Journal Article